Company Profile
Sarepta Therapeutics Stock Price, News & Analysis
- Ticker:
- SRPT
- Exchange:
- NASDAQ
- Sector:
- 基因治疗
- Location:
- Headquartered in Cambridge, Massachusetts and listed on NASDAQ, Sarepta is followed within the genetic medicines universe for its exposure to rare-disease catalysts and specialized treatment demand.
Stock performance
17.26 USD (-2.21%)
Close
Last updated: June 23, 2026 at 00:00
1.82B USD
Market cap
Why the stock is moving
SRPT is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Sarepta Therapeutics is a genetic medicines company focused on neuromuscular disease, with investors watching how its RNA and gene-therapy programs translate into durable clinical and commercial value.
Geographic Base and Sector Classification
Headquartered in Cambridge, Massachusetts and listed on NASDAQ, Sarepta is followed within the genetic medicines universe for its exposure to rare-disease catalysts and specialized treatment demand.
Business Model Characteristics
Sarepta combines commercial execution with pipeline development, so the market pays close attention to trial updates, regulatory milestones, and label expansion opportunities.
Position Within the Biotechnology Landscape
Compared with larger commercial biotech names, Sarepta sits closer to the catalyst-driven side of the landscape, where development updates can quickly reprice the stock.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Sarepta Therapeutics to Participate in Upcoming Investor Conferences
Source: Sarepta Therapeutics
- 02
Sarepta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
Source: Sarepta Therapeutics
- 03
Sarepta Therapeutics Announces First Quarter 2026 Financial Results and Recent Corporate Developments
Source: Sarepta Therapeutics
- 04
Sarepta Therapeutics Announces Commercial Launch of ELEVIDYS in Japan
Source: Sarepta Therapeutics
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Sarepta Therapeutics (SRPT)?
Sarepta Therapeutics (SRPT) most recently closed at 17.26 USD, a -2.21% move versus the previous session.
What is the market cap of Sarepta Therapeutics (SRPT)?
Sarepta Therapeutics currently has a market capitalization of 1.82B USD on BioPharmSignal.
What does Sarepta Therapeutics do?
Sarepta Therapeutics is a genetic medicines company focused on neuromuscular disease, with investors watching how its RNA and gene-therapy programs translate into durable clinical and commercial value.
On which exchange is SRPT stock listed?
Sarepta Therapeutics (SRPT) is associated with NASDAQ, Headquartered in Cambridge, Massachusetts and listed on NASDAQ, Sarepta is followed within the genetic medicines universe for its exposure to rare-disease catalysts and specialized treatment demand., 基因治疗.
What is Sarepta?
Sarepta Therapeutics is a genetic medicines company focused on neuromuscular disease, with investors watching how its RNA and gene-therapy programs translate into durable clinical and commercial value.
Which conditions is Sarepta Therapeutics targeting with Sarepta?
Sarepta Therapeutics is associated with genetic disease based on its company overview and current catalyst commentary.
What is Therapeutics?
Sarepta Therapeutics is a genetic medicines company focused on neuromuscular disease, with investors watching how its RNA and gene-therapy programs translate into durable clinical and commercial value.